1218
J. Eames et al.
LETTER
131.3, 129.6, 129.0, 127.6, 126.8 (Ar), 82.2 (CO), 72.0
(CHO), 64.0 (COSi), 56.3 (CHSPh), 42.2 (CH2), 33.1 (CH2),
30.4 and 28.2 (CH3) 27.4 (CH2), 27.1 (t-Bu) and 22.1
(CH3CH); m/z 489 (15%, M - CH3), 447 (25, M - t-Bu), 337
(M - t-Bu - PhS) and 110.0 (20, PhSH).
syn- and anti-30, and about 30% of the product of a [1,2]-SPh
shift, the THF anti-31
OH
OH
OH
PhS
PhS
Typical Procedure for [1,4] Cascade: e.g. preparation of syn-
28: TBAF (0.3 mL, 1 M solution in THF, 0.3 mmol) was
added to a solution of diol anti-27 (0.16 g, 0.3mmol) in THF
(3 mL) and stirred for 20 h at r.t. The solvent was removed
under reduced pressure and the residue was redissolved in
CH2Cl2 (30 mL). Pyridine (0.5 mL) and TsCl (54 mg, 0.3
mmol) was added, and the solution was stirred overnight. The
organic phase was washed with HCl (5 mL, 3 M), NaHCO3 (5
mL), brine (5 mL) and dried over MgSO4. The solvent was
removed under reduced pressure and the residue was further
purified by column chromatography (light petroleum (40-
60 °C)/ether 9:1) to give the THF syn-28 (31 mg, 38%) as an
oil; vmax (film, CDCl3)/cm-1 3500-3300 (OH) and 1551 (PhS);
dH(200MHz, CDCl3) 7.44-7.20 (5H, m, SPh), 3.79 (1H, m,
CHOH), 2.92-2.95 (2H, m, CH2SPh), 2.21-2.28 (2H, m,
CH2CHOH), 1.95-2.01 (1H, m, CHAHB), 1.63-1.79 (3H, m,
CHAHB and CH2), 1.21 (6H, s, 2 x, CH3) and 1.19 (3H, s,
CH3); dC(50MHz, CDCl3) 136.5, 128.8, 128.6, 125.7 (SPh),
87.1 (C-O), 82.6 (CO), 82.0 (CHOH), 44.2 (CSPh), 34.7, 32.2,
28.1 and 25.6; m/z 280 (2%, M) and 110 (30, PhS).
TsCl
pyr
OH
OH
SPh
+
O
OH
1:1 syn:anti-30
29
30% anti-31
Scheme 7
(17) Heathcock, C. H.; Buse, C. T.; Kleschick, W. A.; Pirrung, M.
C.; Sohn, J. E.; Lampe, J. J. Org. Chem. 1980, 45, 1066.
(18) Selected experimental and spectroscopic details;
Typical experimental procedure for [1,2] cascade sequence:
e.g. THF syn-anti-21: TsOH (3.4 mg, 0.02 mmol) was added
to a stirred solution of diol syn-anti-15 (52 mg, 0.1 mmol) in
CH2Cl2 (5 mL). The solution was refluxed for 5 min, cooled
to room temperature and filtered through a silica plug. The
solvent was removed under reduced pressure to give the THF
syn-anti-21 (48 mg, 96%) as an oil; vmax (film, CDCl3)/cm-1
1550 (SPh); dH(400MHz, CDCl3) 7.67-7.20 (15 H, m, Ar),
4.07 (1 H, dq J 9.8 and 5.9, CHCH3), 3.65 (2H, t, J 6.2,
CH2OSi), 3.44 (1 H, dd, J 11.0 and 6.8, CHSPh), 2.45 (1 H, q,
J 5.64, CHAHB), 1.70-1.85 (2H, m, CH2), 1.52-1.59 (2H, m,
CH2), 1. 25 (3 H, s, CH3), 1.26 (3 H, d, J 6.13, CH3CH) and
1.03 (9H, s, t-Bu); dC(100MHz, CDCl3) 137.4, 137.2, 135.8,
Article Identifier:
1437-2096,E;1999,0,08,1215,1218,ftx,en;L14699ST.pdf
Synlett 1999, No. 8, 1215–1218 ISSN 0936-5214 © Thieme Stuttgart · New York